Cargando…
Diagnostic Accuracy of Magnetic Resonance Imaging Measures of Brain Atrophy Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Degeneration
IMPORTANCE: The accurate diagnosis of progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) is hampered by imperfect clinical-pathological correlations. OBJECTIVE: To assess and compare the diagnostic value of the magnetic resonance parkinsonism index (MRPI) and other magnetic res...
Autores principales: | Illán-Gala, Ignacio, Nigro, Salvatore, VandeVrede, Lawren, Falgàs, Neus, Heuer, Hilary W., Painous, Cèlia, Compta, Yaroslau, Martí, Maria J., Montal, Victor, Pagonabarraga, Javier, Kulisevsky, Jaime, Lleó, Alberto, Fortea, Juan, Logroscino, Giancarlo, Quattrone, Andrea, Quattrone, Aldo, Perry, David C., Gorno-Tempini, Maria Luisa, Rosen, Howard J., Grinberg, Lea T., Spina, Salvatore, La Joie, Renaud, Rabinovici, Gil D., Miller, Bruce L., Rojas, Julio C., Seeley, William W., Boxer, Adam L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055455/ https://www.ncbi.nlm.nih.gov/pubmed/35486397 http://dx.doi.org/10.1001/jamanetworkopen.2022.9588 |
Ejemplares similares
-
Genotype–Phenotype Correlation in Progressive Supranuclear Palsy Syndromes: Clinical and Radiological Similarities and Specificities
por: Ruiz-Barrio, Iñigo, et al.
Publicado: (2022) -
Tau pathology in neurodegenerative disease: disease mechanisms and therapeutic avenues
por: Samudra, Niyatee, et al.
Publicado: (2023) -
Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care
por: Bluett, Brent, et al.
Publicado: (2021) -
Symptomatic amyloid‐related imaging abnormalities in an APOE ε4/ε4 patient treated with aducanumab
por: VandeVrede, Lawren, et al.
Publicado: (2020) -
Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab
por: VandeVrede, Lawren, et al.
Publicado: (2023)